Cannabis Webinar Wednesday - Cannabis and Social Equity Programs
Cannabis Webinar Wednesday - Cannabis and Social Equity Programs
Join Sheppard Mullin’s Cannabis Industry Team leaders, as they discuss social equity programs in the cannabis industry. This webinar will analyze how local governments have sought to recognize and address the long-term impact that federal and state cannabis enforcement policies have had on communities of color. The presentation will also provide tips on how to apply for licenses through social equity programs and enter the cannabis industry. If your cannabis-related business aspirations have been impacted by the war on drugs, you have a cannabis-related conviction or you are a member of a racial or ethnic minority group, this webinar is for you.
When
Wednesday, June 24, 2020
12:00 p.m. - 1:00 p.m. PT
2:00 p.m. - 3:00 p.m. CT
3:00 p.m. - 4:00 p.m. ET
Where
Zoom Webinar
*Webinar details will be emailed to you after you register*
Complimentary Program
Presented By:
- Danielle Moore, Associate, Sheppard Mullin
- Cedric Powell, Associate, Sheppard Mullin
MCLE*
CA
This activity has been approved for Minimum 1 Continuing Legal Education credit by the State Bar of California. Sheppard Mullin Richter & Hampton LLP certifies that this activity conforms to the standards for approved education activities prescribed by the rules and regulations of the State Bar of California governing minimum continuing legal education.
NY
This program has been approved in accordance with the requirements of the New York State Continuing Legal Education Board for a maximum of 1 credit hour which may be applied toward the Areas of Professional Practice requirement, and is suitable for both transitional and non-transitional attorneys.
MCLE attendance certificates will be distributed following the webinar upon completion of an evaluation.
*You must attend the full webinar to receive credit
Click here for more information on Sheppard Mullin's Cannabis Team.
For up-to-date information and recent developments, visit our Coronavirus (COVID-19) Insights page.
Questions? Contact Belinda Ashong via email.